Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivolumab in Localized Deficient Mismatch Repair/Microsatellite Instability-High Gastric or Esophagogastric Junction Adenocarcinoma: The GERCOR NEONIPIGA Phase II Study
出版年份 2022 全文链接
标题
Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivolumab in Localized Deficient Mismatch Repair/Microsatellite Instability-High Gastric or Esophagogastric Junction Adenocarcinoma: The GERCOR NEONIPIGA Phase II Study
作者
关键词
-
出版物
JOURNAL OF CLINICAL ONCOLOGY
Volume -, Issue -, Pages -
出版商
American Society of Clinical Oncology (ASCO)
发表日期
2022-08-16
DOI
10.1200/jco.22.00686
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Is it Time Yet for Adjuvant Immunotherapy for Patients with DNA Mismatch Repair Deficient Gastric Cancer?
- (2022) Jennifer R. Eads ANNALS OF SURGICAL ONCOLOGY
- Determinants of Response and Intrinsic Resistance to PD-1 Blockade in Microsatellite Instability-High Gastric Cancer
- (2021) Minsuk Kwon et al. Cancer Discovery
- PREVALENCE AND PROGNOSIS OF MICROSATELLITE INSTABILITY IN OESOGASTRIC ADENOCARCINOMA, NORDICAP 16-01
- (2021) My-Linh Tran-Minh et al. Clinics and Research in Hepatology and Gastroenterology
- Assessment of Pembrolizumab Therapy for the Treatment of Microsatellite Instability–High Gastric or Gastroesophageal Junction Cancer Among Patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Clinical Trials
- (2021) Joseph Chao et al. JAMA Oncology
- Uselessness and danger of dilating obstructive esophageal for staging purpose: a confirmation
- (2021) Barbara Noiret et al. ANNALS OF THORACIC SURGERY
- Postoperative outcomes after laparoscopic or open gastrectomy. A national cohort study of 10,343 patients
- (2021) Alexandre Challine et al. EJSO
- Prognostic and predictive value of mismatch repair deficiency in gastric and gastroesophageal junction adenocarcinoma patients receiving neoadjuvant or adjuvant chemotherapy
- (2021) Ziyu Li et al. JOURNAL OF SURGICAL ONCOLOGY
- First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial
- (2021) Yelena Y Janjigian et al. LANCET
- Adjuvant Chemotherapy for Gastric Cancer Patients with Mismatch Repair Deficiency or Microsatellite Instability: Systematic Review and Meta-Analysis
- (2021) Run Cong Nie et al. ANNALS OF SURGICAL ONCOLOGY
- Chemotherapy for resectable microsatellite instability-high gastric cancer?
- (2020) Florian Lordick LANCET ONCOLOGY
- Challenges in the treatment of gastric cancer in the older patient
- (2020) Nalinie Joharatnam-Hogan et al. CANCER TREATMENT REVIEWS
- Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers
- (2020) Myriam Chalabi et al. NATURE MEDICINE
- Incidence and Grading of Complications After Gastrectomy for Cancer Using the GASTRODATA Registry
- (2020) Gian Luca Baiocchi et al. ANNALS OF SURGERY
- Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
- (2019) Salah-Eddin Al-Batran et al. LANCET
- Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability As a Biomarker in Gastric Cancer
- (2019) Filippo Pietrantonio et al. JOURNAL OF CLINICAL ONCOLOGY
- Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
- (2018) Julie R. Brahmer et al. JOURNAL OF CLINICAL ONCOLOGY
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Prognostic significance of microsatellite-instability in gastric and gastroesophageal junction cancer patients undergoing neoadjuvant chemotherapy
- (2018) Georg Martin Haag et al. INTERNATIONAL JOURNAL OF CANCER
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- The impact of frailty and sarcopenia on postoperative outcomes in older patients undergoing gastrectomy surgery: a systematic review and meta-analysis
- (2017) Yanjiao Shen et al. BMC Geriatrics
- Mismatch Repair Deficiency, Microsatellite Instability, and Survival
- (2017) Elizabeth C. Smyth et al. JAMA Oncology
- Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
- (2016) E. C. Smyth et al. ANNALS OF ONCOLOGY
- Tumor regression grade in gastric cancer: Predictors and impact on outcome
- (2016) Aaron U. Blackham et al. JOURNAL OF SURGICAL ONCOLOGY
- Molecular key to understand the gastric cancer biology in elderly patients-The role of microsatellite instability
- (2016) Karol Polom et al. JOURNAL OF SURGICAL ONCOLOGY
- Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial
- (2016) Salah-Eddin Al-Batran et al. LANCET ONCOLOGY
- Strong Prognostic Value of Microsatellite Instability in Intestinal Type Non-cardia Gastric Cancer
- (2015) Daniele Marrelli et al. ANNALS OF SURGICAL ONCOLOGY
- Is microsatellite instability a prognostic marker in gastric cancer?: A systematic review with meta-analysis
- (2014) Yoon Young Choi et al. JOURNAL OF SURGICAL ONCOLOGY
- Significance of Histopathological Tumor Regression After Neoadjuvant Chemotherapy in Gastric Adenocarcinomas
- (2011) Karen Becker et al. ANNALS OF SURGERY
- Posttherapy Nodal Status, Not Graded Histologic Response, Predicts Survival after Neoadjuvant Chemotherapy for Advanced Gastric Cancer
- (2011) Kazumasa Fujitani et al. ANNALS OF SURGICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now